No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
UHS240517C200000
- 2.05
- 0.000.00%
15min DelayTrading Mar 28 11:52 ET
0.00High0.00Low
0.00Open2.05Pre Close0 Volume102 Open Interest200.00Strike Price0.00Turnover92.41%IV17.60%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry2.05Time Value100Contract SizeAmericanOptions Type0.1676Delta0.0102Gamma83.81Leverage Ratio-0.3590Theta0.0063Rho14.05Eff Leverage0.0664Vega
Intraday
- 5D
- 1D
News
Decoding Universal Health Services Inc (UHS): A Strategic SWOT Insight
10-Q: Quarterly report
Universal Health Is Maintained at Sector Perform by RBC Capital
Universal Health Is Maintained at Sector Perform by RBC Capital
Express News | RBC Capital Maintains Sector Perform on Universal Health Servs, Raises Price Target to $189
Express News | Universal Health Services Inc : RBC Raises Target Price to $189 From $183
Express News | NYSE Order Imbalance 161402.0 Shares on Buy Side
Comments
Insider selling at Universal Health Services, especially by Executive VP Steve Filton, may worry investors. Despite some insider buying, the long-term outlook isn't very positive. High insider ownership suggests management's interests align with shareholders, but insider selling warrants caution.
Universal Health Services Insiders Sold US$8.5m Of Shares Suggesting Hesitancy 1
The declining ROCE trend at Universal Health Services does not inspire confidence. Despite the company's reinvestment in its own business, returns are shrinking. Investors looking for a multi-bagger might want to consider other options.
1
The EPS decline may not reflect the business's evolution. Other metrics, like revenue growth and TSR, could be positive signs for long-term investors.
1
Universal Health Services is still a bargain according to the price multiple model. Its volatile share price could provide more buying opportunities. The company's optimistic future growth hasn't been fully factored into the share price yet.
Insider selling over the past year may worry shareholders, despite high insider ownership suggesting aligned interests. This activity raises doubts in the company's valuation.
Read more